Estimation of the Antirelapse Efficacy of Tafenoquine, Using Plasmodium vivax Genotyping

Prevention of relapse of Plasmodium vivax infection is a key treatment goal in malaria. Use of P. vivax genotyping in a multicenter, double-blind, randomized, placebo-controlled phase 2b study in Peru, India, Thailand, and Brazil allowed determination of genetically heterologous or homologous P. viv...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Infect Dis
Glavni autori: Beck, Hans-Peter, Wampfler, Rahel, Carter, Nick, Koh, Gavin, Osorio, Lyda, Rueangweerayut, Ronnatrai, Krudsood, Srivcha, Lacerda, Marcus V., Llanos-Cuentas, Alejandro, Duparc, Stephan, Rubio, Justin P., Green, Justin A.
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2016
Teme:
Major Articles and Brief Reports
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4747625/
https://ncbi.nlm.nih.gov/pubmed/26500351
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiv508
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items